Announced Tue, 21 Jul · 15:08 IST
35th AGM on Aug 14, 2026; Rs. 5 dividend and board changes
Board & Shareholder Meetings View source PDF
STAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-1.2%1-day move
₹1055.00
prior close
₹1051.90
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.0-0.1-0.1—-1.2-2.1-3.2-1.1——————
Up moveDown movePending
AI summary
Strides Pharma 35th AGM on August 14, 2026 via video conferencing. Resolutions: FY26 financials, Rs. 5 final dividend (record date July 31, 2026), re-appoint Founder Arun Kumar, commission up to Rs. 50 lakhs yearly per Non-Executive Director for 3 years, appoint Aditya Arun Kumar as Non-Executive Director, and appoint Venkata Seetharama Raju Pakalapati as Executive Director for 3 years at Rs. 5.04 crores yearly. E-voting: August 10-13, 2026.
Likely market impact
Final dividend, board changes need shareholder approval. New Executive Director gets Rs. 5.04 crore pay; promoter son moves to non-executive role.